T0	Disease 237 244	cancers
#1	AnnotatorNotes T0	DOID:162
T10	Gene-Protein 818 821	CEA
T11	Disease 913 919	tumour
#3	AnnotatorNotes T11	DOID:162
T12	Disease 969 975	cancer
#4	AnnotatorNotes T12	DOID:14566|DOID:162
T15	Disease 1095 1102	tumours
#6	AnnotatorNotes T15	DOID:162
T16	Disease 1137 1142	NSCLC
T17	Disease 1144 1161	gastric carcinoma
#8	AnnotatorNotes T17	DOID:5517
T18	Disease 1166 1183	colorectal cancer
#9	AnnotatorNotes T18	DOID:9256
T19	Disease 1211 1217	tumour
T21	Disease 1263 1268	NSCLC
T23	Disease 1511 1517	cancer
T25	Disease 1644 1662	malignant features
#13	AnnotatorNotes T25	DOID:1909
T27	Disease 1749 1754	NSCLC
T28	Disease 1914 1919	NSCLC
T3	Disease 474 480	cancer
#16	AnnotatorNotes T3	DOID:162
T5	Disease 563 575	colon cancer
#17	AnnotatorNotes T5	DOID:219
T6	Disease 588 613	colon and prostate cancer
#18	AnnotatorNotes T6	DOID:219,DOID:10283
T8	Disease 689 694	NSCLC
#19	AnnotatorNotes T8	DOID:3908
T1	Gene-Protein 83 94	E-selectins
#2	AnnotatorNotes T1	HGNC:10721
T2	Gene-Protein 651 661	E-selectin
T4	Gene-Protein 793 803	E-selectin
T7	Gene-Protein 496 500	CD44
#11	AnnotatorNotes T7	HGNC:1681
T9	Gene-Protein 520 559	hematopoietic cell E-/L-selectin ligand
#20	AnnotatorNotes T9	HGNC:1681
T14	Gene-Protein 1885 1895	E-selectin
T20	Biomarker 1587 1614	CEA-E-selectin interactions
T22	Gene-Protein 1875 1878	CEA
T24	Gene-Protein 581 584	CEA
#10	AnnotatorNotes T24	HGNC:1819
T26	Gene-Protein 414 424	E-selectin
T29	Gene-Protein 734 737	CEA
T30	Gene-Protein 988 991	CEA
T31	Gene-Protein 1242 1245	CEA
T32	Gene-Protein 1673 1676	CEA
T33	Gene-Protein 1587 1590	CEA
T34	Gene-Protein 1591 1601	E-selectin
T35	Gene-Protein 1423 1426	CEA
T36	Biomarker 286 324	sLeˣ/sLeᵃ -decorated protein scaffolds
R1	Association Arg1:T20 Arg2:T25	
T37	Biomarker 402 432	carriers of E-selectin ligands
T38	Biomarker 651 669	E-selectin ligands
R2	Association Arg1:T37 Arg2:T3	
T39	Biomarker 496 510	CD44 glycoform
T40	Biomarker 581 584	CEA
R4	Association Arg1:T40 Arg2:T6	
R3	Association Arg1:T39 Arg2:T5	
T41	Gene-Protein 840 861	endothelial selectins
T42	Biomarker 818 861	CEA interactions with endothelial selectins
T13	Biomarker 1423 1426	CEA
R5	Association Arg1:T13 Arg2:T23	
T43	Biomarker 1236 1245	Serum CEA
R6	Prognostic-Poor Arg1:T43 Arg2:T21	
T44	Collection 1095 1217	tumours with epithelial origin, including NSCLC, gastric carcinoma and colorectal cancer, for which it is used as a tumour
T45	Biomarker 988 1091	CEA is a glycoprotein with low and limited expression in normal tissues, but is detected at high levels
R7	Association Arg1:T45 Arg2:T44	
T46	Collection 913 975	tumour cells to the endothelium, consequently promoting cancer
R8	Association Arg1:T42 Arg2:T46	
#5	AnnotatorNotes T26	HGNC:10721
#7	AnnotatorNotes T40	C548518
#12	AnnotatorNotes T39	C497483
T47	Biomarker 1681 1690	sLeˣ/sLeᵃ
T48	Collection 1673 1690	CEA and sLeˣ/sLeᵃ
T49	Biomarker 1673 1676	CEA
R9	Association Arg1:T48 Arg2:T27	
T50	Biomarker 1854 1902	sLeˣ/sLeᵃ-associated CEA as an E-selectin ligand
R10	Association Arg1:T50 Arg2:T28	
T51	Biomarker 1285 1314	advanced stage of the disease
T52	Biomarker 1316 1341	poor therapeutic response
T53	Biomarker 1343 1356	early relapse
T54	Biomarker 1361 1377	shorter survival
#14	AnnotatorNotes T41	HGNC:10721
